A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia

Completed · Phase 2

Conditions studied: Pneumonia, Bacterial

In brief

This study will assess the efficacy and safety of intravenous beta-lactam, in comparison with ceftriaxone, in hospitalized patients with community-acquired pneumonia not caused by Legionella. The anticipated time on study treatment is 3-12 months and the target sample size is 100-500 individuals.

Key facts

Study ID

NCT00111644

Run by

Hoffmann-La Roche

People needed

302

Starts

2005-03-01

Expected to finish

2007-01-01

Last updated by the study team

2016-11-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• male or female patients at least 18 years of age;
• hospitalization with community-acquired pneumonia or development of pneumonia within 48 hours of being hospitalized for another reason;
• fever;
• new or increased productive cough;
• chest pain, shortness of breath, or rapid breathing.

You may not qualify if…

• requiring intubation or ventilation;
• nursing home or extended care within 60 days before study;
• concomitant bacterial infection requiring antibiotics;
• long-term immunosuppressive therapy.

Where it is running

• Study site — New Orleans, Louisiana, United States
• Study site — Shreveport, Louisiana, United States
• Study site — Detroit, Michigan, United States
• Study site — Butte, Montana, United States
• Study site — Holmdel, New Jersey, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Buenos Aires, Argentina
• Study site — Buenos Aires, Argentina
• Study site — Buenos Aires, Argentina
• Study site — Buenos Aires, Argentina
• Study site — Buenos Aires, Argentina
• Study site — Buenos Aires, Argentina
• Study site — Buenos Aires, Argentina
• Study site — Ciudadela, Argentina
• Study site — Córdoba, Argentina
• Study site — Córdoba, Argentina
• Study site — Granadero Baigorria, Argentina
• Study site — Paraná, Argentina
• Study site — Rosario, Argentina
• Study site — Rousse, Bulgaria
• Study site — Sofia, Bulgaria
• Study site — Sofia, Bulgaria
• Study site — Sofia, Bulgaria
• Study site — Santiago, Chile
• Study site — Valdivia, Chile

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.